ABIGAIL RICHARDSON: Open Payments
NPI 1124648670 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 33 payments from 6 companies in 2025. Trend: 2023 $716 · 2024 $739 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $495 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $246 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Lundbeck LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, FARXIGA, TRELEGY ELLIPTA, REXULTI, BREZTRI, MOUNJARO, AIRSUPRA.
Industry payments across WV — which companies pay providers there.
